MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Impulse Control Disorders in a Brazilian population with Parkinson´s disease -an observational study

    B. Veiga, V. Borges, H. Ferraz, C. Aquino, C. Giacominelli, SM. Silva, S. Lestingi (São Paulo, Brazil)

    Objective: To Analyse Impulse Control Disorders (ICDs) and Related Behaviors (RB) in 36 Brazilian patients with Parkinson´s disease (PD) and compare the cognition of the…
  • 2019 International Congress

    Glycopyrrolate as inhalation for treating sialorrhea in Parkinson’s Disease

    L. Velzen, J. Masselink, L. Dorresteijn, K. Movig (Enschede, Netherlands)

    Objective: To evaluate the safety, tolerability and effect of glycopyrrolate inhalations in PD patients with sialorrhea. Background: Sialorrhea is reported in up to 60 percent…
  • 2019 International Congress

    Exploratory analysis of the relationship between pain and mood disturbances in Parkinson’s disease

    C. Vila, A. Sparks, P. Imbriani, N. Caputi, L. Covington, T. Schirinzi, S. Natoli, A. Pisani, P. Ghosh (Washington, DC, USA)

    Objective: This study aims to investigate the relationship between pain and mood disturbances in patients with Parkinson disease (PD). Background: Pain and mood disturbances are…
  • 2019 International Congress

    Effect of Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy on non-motor symptoms in patients with advance Parkinson’s disease

    V. Vuletic (Rijeka, Croatia)

    Objective: Our aim was to see effects of deep brain stimulation (DBS) and continuous infusion of levodopa-carbidopa intestinal gel (LCIG) on nonmotor symptoms in advanced…
  • 2019 International Congress

    Frequency, course and predictors of fatigue in Parkinson’s disease patients and population-based controls

    E. Warrlich, EJ. Vollstedt, R. Modreanu, B. Hauptmann, V. Tadic, S. Tunc, C. Kritzinger, J. Prasuhn, A. Balck, M. Borsche, H. Hanssen, N. Brüggemann, C. Klein, M. Kasten (Luebeck, Germany)

    Objective: To assess fatigue frequency, course, and predictors in a large and diverse cohort of Parkinson’s disease (PD) patients and controls. Background: Fatigue is a…
  • 2019 International Congress

    Characterizing olfactory impairment in patients with Parkinson’s disease and related disorders

    Y. Watanabe, K. Suzuki (Mibu, Shimotsuga, Tochigi, Japan)

    Objective: To characterize olfactory impairment in Parkinson’s disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Background: In the previous study, we found…
  • 2019 International Congress

    Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full

    D. Weintraub, C. Caspell-Garcia, H. Cho, T. Simuni, A. Siderowf, C. Coffey, D. Aarsland, R. Alcalay, L. Chahine, J. Eberling, A. Espay, J. Hamilton, J. Leverenz, I. Litvan, I. Richard, L. Rosenthal, M. York (Philadelphia, PA, USA)

    Objective: To describe the cognitive-psychiatric course in the first 5 years of diagnosed Parkinson disease (PD). Background: Although common, little is known about the differential…
  • 2019 International Congress

    Non-motor symptoms burden grading in Parkinson disease with the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS)

    D. Weintraub, C. Rodriguez-Blazquez, A. Schrag, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

    Objective: To identify cut-off points on the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS) for non-motor symptoms (NMS) burden grading. Background: NMS burden…
  • 2019 International Congress

    IMPACT OF PAIN ON STROKE AND HYPERTENSION AS COMORBIDITIES IN PARKINSON’S DISEASE

    V. Wijaya, R. Pinzon, A. Al Jody (Yogyakarta, Indonesia)

    Objective: This study aimed to report the prevalence and type of pain in patients with PD, and to determine the relationship between each type of…
  • 2019 International Congress

    Investigation of back pain in patients with Parkinson’s Disease

    O. Yaremchuk, I. Yaremchuk (Chernivtsi, Ukraine)

    Objective: The aim of this study was to investigate prevalence and influence of different methods of treatment of back pain in patients with Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 1136
  • 1137
  • 1138
  • 1139
  • 1140
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley